Billionaire Profile
L
Global Rank
#1390

Image: National Institute on Alcohol Abuse and Alcoholism (U.S.) California College of Medicine | Public domain | via Wikimedia Commons

Leena Tewari

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$3.089B
Estimated based on Pharmaceuticals stock value as of April 21, 2026
0% (24h)
Age
68
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Leena Tewari is an Indian businesswoman and philanthropist, known for her significant contributions to the pharmaceutical industry and her philanthropic endeavors. As of 2024, she is the chairperson of USV Private Limited, a leading pharmaceutical company based in Mumbai, India. Her net worth is estimated at $3.9 billion, reflecting her success in the industry. Leena Tewari’s career has been marked by her leadership at USV, guiding the company's growth and expansion. She is recognized not only for her business acumen but also for her dedication to supporting underprivileged communities through healthcare and educational initiatives.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

Leena Gandhi Tewari was born on March 9, 1957, in Mumbai, India, into a prominent business family. Her grandfather, Vithal Balkrishna Gandhi, founded USV Private Limited in 1961, which instilled in her an early interest in business and entrepreneurship. She pursued her education at the University of Mumbai, earning a Bachelor of Commerce degree, and later obtained a Master of Business Administration from Boston University.

Rise to Success

After completing her education, Leena Tewari joined USV Private Limited. Through her leadership, she has guided the company to new heights. Initially, USV was an importer of medicines, but under Tewari's strategic vision, it ventured into manufacturing. A key development in USV's growth was the acquisition of the German generics company Juta Pharma in 2018, reflecting Tewari's ambitions for the company's international expansion. USV specializes in diabetic and cardiovascular drugs as well as biosimilar drugs, injectables, and active pharmaceutical ingredients. The company operates in 75 countries globally. USV’s annual revenue was ₹5,200Cr as of March 31, 2025.

Key Business Strategies

Under Leena Tewari's leadership, USV has focused on innovation and strategic partnerships to drive growth. The company invests a percentage of its revenue in R&D and has received patents. USV has also been expanding its product portfolio, including biosimilars and injectables, to cater to growing market demands. Furthermore, the company has been expanding internationally. Key brands include Glycomet, Ecosprin, and Roseday.

Philanthropy

Leena Tewari is actively involved in philanthropic work, with a focus on healthcare and education for underprivileged communities. In 2019, she ranked third among women philanthropists on the Hurun India Philanthropy List, donating ₹34 crore to social causes. Her initiatives include supporting the Dr. Sushila Gandhi Centre for Underprivileged Women.

Career Milestones

1961

USV Private Limited Founded

USV Private Limited, a multinational pharmaceutical and biotechnology company, was founded by Vithal Balkrishna Gandhi in Mumbai.

1980s

Joined USV Private Limited

Leena Gandhi Tewari joined USV Private Limited.

2018

Acquired Juta Pharma

USV expanded abroad by acquiring Germany's Juta Pharma.

2022

Daughter Joins Board

Daughter, Aneesha Gandhi Tewari, joined the USV board.

Philanthropy & Social Impact

Healthcare and Education

Dr. Sushila Gandhi Centre for Underprivileged Women

Undisclosed

Supports women through education, mentoring, and computer training.

Business Philosophy & Leadership

Leadership Principles

Innovation

Commitment to develop innovative products and solutions.

Reliability

To be recognized as a reliable provider of healthcare products and services.

People-Centric

Create a work environment that values people and promotes learning.